Heparan sulfate proteoglycans present PCSK9 to the LDL receptor

Coronary artery disease is the main cause of death worldwide and accelerated by increased plasma levels of cholesterol-rich low-density lipoprotein particles (LDL). Circulating PCSK9 contributes to coronary artery disease by inducing lysosomal degradation of the LDL receptor (LDLR) in the liver and...

Descripción completa

Detalles Bibliográficos
Autores principales: Gustafsen, Camilla, Olsen, Ditte, Vilstrup, Joachim, Lund, Signe, Reinhardt, Anika, Wellner, Niels, Larsen, Torben, Andersen, Christian B. F., Weyer, Kathrin, Li, Jin-ping, Seeberger, Peter H., Thirup, Søren, Madsen, Peder, Glerup, Simon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593881/
https://www.ncbi.nlm.nih.gov/pubmed/28894089
http://dx.doi.org/10.1038/s41467-017-00568-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593881/
https://www.ncbi.nlm.nih.gov/pubmed/28894089
http://dx.doi.org/10.1038/s41467-017-00568-7

Ejemplares similares